Skip to main content
. 2014 Aug 12;19(9):966–974. doi: 10.1634/theoncologist.2014-0037

Figure 3.

Figure 3.

Overall survival in patients who achieved disease control (responders) vs. patients who did not achieve disease control (nonresponders) during everolimus treatment. Disease control is defined as stable disease plus partial response plus complete response. p < .0001.